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Abstract. Subsurface fluorescence imaging is desirable for medical applications, including protoporphyrin-IX
(PpIX)-based skin tumor diagnosis, surgical guidance, and dosimetry in photodynamic therapy. While tissue optical
properties and heterogeneities make true subsurface fluorescence mapping an ill-posed problem, ultrasound-
guided fluorescence-tomography (USFT) provides regional fluorescence mapping. Here USFT is implemented
with spectroscopic decoupling of fluorescence signals (auto-fluorescence, PpIX, photoproducts), and white
light spectroscopy-determined bulk optical properties. Segmented US images provide a priori spatial information
for fluorescence reconstruction using region-based, diffuse FT. The method was tested in simulations, tissue homo-
geneous and inclusion phantoms, and an injected-inclusion animal model. Reconstructed fluorescence yield was
linear with PpIX concentration, including the lowest concentration used, 0.025 μg∕ml. White light spectroscopy
informed optical properties, which improved fluorescence reconstruction accuracy compared to the use of fixed,
literature-based optical properties, reduced reconstruction error and reconstructed fluorescence standard deviation
by factors of 8.9 and 2.0, respectively. Recovered contrast-to-background error was 25% and 74% for inclusion
phantoms without and with a 2-mm skin-like layer, respectively. Preliminary mouse-model imaging demonstrated
system feasibility for subsurface fluorescence measurement in vivo. These data suggest that this implementation of
USFT is capable of regional PpIX mapping in human skin tumors during photodynamic therapy, to be used in
dosimetric evaluations. © The Authors. Published by SPIE under a Creative Commons Attribution 3.0 Unported License. Distribution or reproduction
of this work in whole or in part requires full attribution of the original publication, including its DOI. [DOI: 10.1117/1.JBO.18.4.046008]
Keywords: tomography; high-frequency ultrasound; dermatology; photodynamic; spectroscopy; subsurface fluorescence.
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1 Introduction
The focus of this work was to develop and test an optimized
system for image-guided fluorescence tomography of subsur-
face skin lesions, with the goal of providing region-based quan-
tification of protoporphyrin IX (PpIX) fluorescence in vivo.
Photodynamic therapy (PDT) based upon PpIX as the photosen-
sitizer is an established, noninvasive dermatologic treatment for
actinic keratosis in the US, and is commonly used ‘off label’ for
cosmetic treatments, and treatment of squamous cell carcinoma
(SCC) and superficial basal cell carcinoma (BCC).1–5 PpIX-
based PDT involves the administration of a precursor molecule,
either aminolevulinic acid (ALA) in the form of Levulan, or
methyl aminolevulinate (MAL) in the form of Metvix. The
induced PpIX accumulates preferentially in epithelial patholo-
gies including SCC and BCC, with tumor-to-background con-
trast from 2:1 to 9:1 depending on the pathology and the
preparation of ALA used.4–6 The photophysically active form
of PpIX is fluorescent, and so the effective fluorescent yield
is an indirect measurement of the active concentration available
for a fixed light delivery.7
While PDT often yields successful treatment outcomes in
superficial (<1 mm thick) BCCs and SCCs, treatment of subsur-
face pathologies at deeper locations has been less successful.8,9
This limit to effectiveness is potentially due to a reduced amount
of ALA, and thus PpIX, at greater depths.10 Additional methods
have been developed to increase PpIX induction including dif-
ferentiation therapy to increase PpIX synthesis and contrast11
and the use of lipophilic ester variations of ALA12 or vertical
micro-channel ablation13,14 to increase ALA penetration. In
order to understand how the influence of these methods on PpIX
concentrations within targeted tissue correlates with treatment
outcomes, a method must be developed to measure in vivo
PpIX fluorescence distributions during PDT treatment.15 PpIX
is a natural fluorophore, so molecular imaging could provide the
spatial distribution information necessary for noninvasive tumor
detection and delimitation,16,17 as well as evaluation and real-
time outcome prediction for PDT.
Toward this goal, diffuse fluorescence tomography (FT) of
tissue can be used for subsurface fluorescence imaging, and
can provide improved quantitative accuracy as compared to
broad-beam surface imaging methods.18–20 Subsurface FT typ-
ically employs an array of fiber optic source-detector pairs to
measure diffusely remitted light, and the data are used to con-
struct depth images from the different light paths sampled.
Ideally, each source-detector pair samples a slightly different
light path through the tissue and numerical method solutions
for the multiple-scattering paths are used to isolate the local con-
tribution of fluorophore concentration to each measurement.20,21
However, mathematical reconstruction of a true, high-resolution
fluorescence image from FT measurements is an ill-posed prob-
lem because the limited number of measured signals does not
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provide a unique solution to the fluorescence distribution map
for the large number of locations within the domain. Earlier
work has shown this inverse problem to be inaccurate without
additional information.19,20 The addition of prior structural seg-
mentation information using MRI,22,23 X-ray computed tomog-
raphy (XRCT),24–27 or ultrasound imaging (US)28–30 can lead to
improved reconstruction of fluorescence using tomography.
Segmentation of tissue geometries into a few regions of interest
converts the ill-posed problem into an over-defined problem
for which a reliable, unique solution can be found, at the cost
of reducing fluorescence imaging resolution to a few regions of
interest.31,32
Of the available imaging modes to measure structural prior
information, US provides fast, low-cost, nonionizing, high-
resolution, spatial information imaging, and high frequency
US-guided FT has been demonstrated to improve fluorescence
recovery in transmission geometry (source and detector fibers
facing on opposite sides of tissue) FT.30 However, US-guided
FT still stands to be improved by three important developments
that we combine in this reported work:
1. Use reflectance geometry (source and detection fibers
on same surface). Reflectance geometry allows seam-
less application with an US transducer and is more rel-
evant to large animal (human) imaging applications.
Most current FT methods use transmission geometry,
which works well for small animals but requires light
transmission through the region of interest, and is thus
less applicable to large animal (human) imaging.
2. Spectroscopic signal decoupling. Most current FT
methods measure fluorescence signals using one or
two wavelengths or band pass-integration measure-
ments,28 and do not adequately account for contami-
nating signals from other fluorophores or tissue/
system autofluorescence in the measured signals.
Sensitivity could be improved with spectrally resolved
techniques to account for multiple fluorescent signals,
such as photo-bleaching products and tissue auto-
fluorescence.29,32,33
3. White light-spectroscopy-informed optical properties.
The current FT reconstruction methods require simu-
lation of tissue optical paths, which in turn requires
knowledge of tissue optical properties or, in the
absence of measured values, choosing tissue optical
properties based on literature standards. However,
tissue optical properties vary temporally and spatially
(μa ¼ 0:001 to 0:1 mm−1 and μs ¼ 0:2 to 4:0 mm−1)
(Ref. 34) and the values used can significantly affect
the reconstructed fluorescence signal.
We present here a high-frequency ultrasound-guided fluores-
cence tomography (USFT) method and system, with significant
improvements over the previously presented system29 that
address the three USFT development objectives outlined above
(reflectance imaging, spectral decoupling, and white light-spec-
troscopy measurement of optical properties). The USFT method
introduced, based on reflectance geometry measurements, incor-
porates fluorescence spectral fitting to isolate the signal of inter-
est from other fluorescent signals, including system and tissue
autofluorescence, and incorporates white light spectral fitting to
measure local tissue optical properties for more accurate light
path simulation and reconstruction of regional fluorescence.
We validate the USFT system and approach for regional quan-
tification of PpIX fluorescence yield in optically homogeneous
and heterogeneous tissue phantoms and present preliminary in
vivo imaging using a tumor-simulating mouse model.
2 Materials and Methods
2.1 Experimental System Design and Construction
A diagram of the US FT imaging system used herein is shown
in Fig. 1. The instrument was originally introduced by Gruber
et al.29 but has undergone significant hardware and software
improvements noted here. It is composed of a Sonix Tablet
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Fig. 1 Ultrasound-guided fluorescence tomography system schematic. (a) Dual transducer co-registration ‘v-block’ slide mount, with an ultrasound
probe on the left and fiber optic linear array on the right. Arrows indicate direction of motion for transition from US mode to FT mode, with both
modalities imaging the same plane. Top inset: side view of optical fibers. (b) FT system schematic, showing the 633 nm light source used for excitation
and fluorescence measurements as well as the white light source used for white light transmission spectroscopy. For fluorescence spectroscopy, move-
able long pass filters remove the 633 nm excitation light to capture emitted fluorescence spectra for each source-detector pair. Bottom inset: cross-
section of fiber probe, showing fiber spacing (2.5 mm).
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(Ultrasonix, Richmond, British Columbia, Canada) high-fre-
quency ultrasound system with a 40 MHz transducer (L40 8/
12, Ultrasonix) coupled to a multi-channel optical tomography
instrument. These modalities are integrated at the tissue inter-
face through a custom dual transducer ‘v-block’ positioning
system which facilitates precise positioning for imaging the
same plane with US and FT sequentially, a process illustrated
in Fig. 1(a). Image acquisition begins by using the US system
to locate the region of interest, such as a subsurface tumor. Once
this imaging plane is located, the positioning arm holding the
‘v-block’ is locked and an US image is captured. Then, the
US transducer is slid away and replaced with the FT optical
fiber array transducer via the sliding v-block design and all opti-
cal projections are acquired. The transducer v-block is designed
such that both transducers image the same plane, allowing direct
use of segmented US images for FT processing.
The optical component of the system consists of 4 source
and 5 detection fiber channels alternating in a single line with
a center-to-center spacing of 2.5 mm [Fig. 1(b)]. The exci-
tation source is a 633 nm laser system with current and temper-
ature regulation (Model 7404, Intense Co., North Brunswick,
New Jersey). The laser output passes through a filter wheel
(FW102C, Thorlabs) containing a 2 OD neutral density filter,
a 650-nm short pass filter, and a beam stop, and is multiplexed
to the four source channels via a 1 × 4 fiber switch (Piezosystem
Jena, Hopedale, Massachusetts). The output of each channel
is coupled to the target tissue by 600 μm fibers (LGOptics,
Germany). The five detection fibers channel light from the target
tissue through custom moveable filter blocks to five compact
spectrometers (USB2000þ, Ocean Optics, Dunedin, Florida)
with spectral range of 540 to 1210 nm. Sources are illuminated
sequentially, while detection fiber spectra are captured in paral-
lel. Dark spectra are captured for each imaging mode using the
same exposure times and light paths with the excitation source
blocked by a beam stop in the filter wheel.
In addition to the fluorescence excitation source, a shuttered
white light source (HL-2000-FHSA, Ocean Optics) has been
incorporated into the optical system, through an additional trans-
ducer fiber, to obtain white light spectroscopy data for explicit
recovery of tissue optical properties. This capability is unique in
fluorescence tomography systems.
The fiber switch, filter wheel, and spectrometers are con-
nected via a USB hub (DUB-H7, D-link) to the Sonix Tablet
Windows-based computer. The detection-side moveable filters,
filter position feedback limit switches, and white light shutter
are controlled or read via NI DAQs (NI USB 6009, National
Instruments). Imaging, including source-detector-pair-dependent
auto-exposure for each imaging mode is controlled via
LabView virtual instrument software (LabView v8.4.2, National
Instruments). Ultrasound image-segmentation, spectral pro-
cessing, and fitting of fluorophore distribution were performed
using Matlab (R2011b, Mathworks, Natick, Massachusetts) and
NIRFAST.35
To acquire data for optical reconstruction, three sets of mea-
surements were recorded [Fig. 2(a) to 2(c)]. Once the fibers were
positioned, excitation intensity was measured for all 20 projec-
tions (four sources and five detectors) [Fig. 2(a)]. During this
acquisition, the source intensity was attenuated at the filter wheel
using a neutral density filter of OD ¼ 2.0 (NE20B, Thorlabs,
Newton, New Jersey) to prevent detector saturation. To acquire
full projection fluorescence data, the neutral density filter at
the filter wheel was replaced with a 650-nm short pass filter
(FES0650, Thorlabs), and 655-nm long pass interference filters
(655ELPF, Omega Optics) were automatically lowered into
each detection channel via movable filter mounts (MFF001,
Thorlabs) attached to custom filter blocks [Fig. 2(b)]. Finally,
a beam stop in the filter wheel blocked the excitation laser,
and white light spectra from a single source were measured at
each detector position to provide five projections for tissue spec-
troscopy [Fig. 2(c)].
2.2 Data Processing
2.2.1 US image segmentation and mesh generation
Ultrasound images were manually segmented into 2 regions:
tumor (fluorescent inclusion), and background bulk tissue
[Fig. 2(d) to 2(f)] using Matlab. Because the US transducer
field of view is narrower than the FTarray, the mask background
was extended laterally. This mask was supplied to a meshing
routine described elsewhere36,37 and recently built into the
NIRFAST package along with source and detector fiber loca-
tions, node density, and mask pixel dimensions as inputs, to pro-
duce a finite element mesh.
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Fig. 2 Sample FT and US images. (a) Excitation light at 633 nm that diffusely propagates between each source-detector pair. (b) Emitted fluorescence
spectra. Note the bump around 700 nm representing PpIX emission. (c) Diffuse white light reflectance spectra. (d) US image of simulated tumor in a
nude mouse (Matrigel injection). (e) Manually segmented US image. (f) The region mask generated from the segmented US image, with source, detec-
tion, and white light fiber positions shown. The boundaries of the mask have been extended laterally.
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2.2.2 White light spectral analysis
Broadband white light spectra in the wavelength range 550 to
900 nm were analyzed using a fitting algorithm that used dif-
fusion theory38 to relate wavelength-dependent estimates of
the reduced scattering coefficient and absorption coefficient to
the calibrated reflectance intensity measured at multiple source-
detector separation distances. Measured spectra were calibrated
using measured intensity (Imeascalibration) and model estimates of
reflectance intensity (Rmodelcalibration) from a phantom of known opti-
cal properties, in this study a phantom with 1% Intralipid.
This calibration was given as:
Rmeassample ¼
Rmodelcalibration
Imeascalibration
Imeassample:
This calibration factor transformed the collected intensity
(Imeassample) from counts/sec to reflectance (R
meas
sample) units of
photons∕mm2, resolving the experimental data into the same
units as exported by the standard diffusion theory model. This
calibrated spectrum was described by a model as:
Rmodelsample ¼ fðμ 0s; μa; nrel; rÞ.
Here, the model estimate of reflectance intensity (Rmodelsample)
includes a wavelength-dependent background scattering model,
expressed as μ 0s ¼ aλ−b, which allows estimation of a combined
Mie- and Rayleigh-type scattering. The model also specified
absorption, μa, as the summation of the contribution of individ-
ual chromophores, as μtotala ¼ Σμiaci. The chromophores within
phantoms in this study included oxygenated and deoxygenated
hemoglobin and water, and analysis of in vivo data also included
collagen. The influence of variation in the index of refraction
(nrel) between calibration phantom and sample was estimated
by incorporating an amplitude factor, as in Refs. 39 and 40.
The fitting algorithm in this investigation estimated scattering
amplitude and slope and chromophore concentrations in order
to minimize the difference between the measured and model
estimated reflectance spectra at each source-detector distance
measured [Fig. 33(c)]. White light spectra-based bulk estimates
of μa and μs’ at excitation (633 nm) and emission (700 nm)
wavelengths were used as inputs to FT reconstructions to
account for variations in bulk tissue optical properties.
2.2.3 Data processing and fluorescence reconstruction
After subtraction of dark signal, spectra were normalized with
respect to exposure times. A three-point median filter was used
to eliminate spikes from each spectrum followed by a 14-point
(5 nm) moving average smoothing filter. A single excitation
value was obtained from the 633 nm peak for each projec-
tion [Fig. 3(d)]. For fluorescence spectra, a linear-least-squares
fitting algorithm32 was used to determine the contributions
from normalized basis spectra for PpIX fluorescence, photo-
product photoprotoporohyrin (pPp),41 and system and tissue
auto-fluorescence [Fig. 3(a)]. The pPp fluorescence basis spec-
tra was approximated using a Gaussian curve centered at 675 nm
with 27 nm full-width-half-maximum, as reported previously by
Kruijt et al.42 The combined system and target auto-fluorescence
spectra were obtained for each detection channel using the
same phantom ingredients without PpIX [Fig. 3(a)]. This analy-
sis yielded a fitted coefficient representing the fluorescence
(a)
(d) (e) (f)
(b) (c)
Fig. 3 Data processing. (a) An example of spectral fitting using PpIX, autofluorescence, and photoproduct (pPp) bases. (b) Sensitivity maps for two
measurements, between source 1-detector 1 (off the inclusion) and source 3-detector 3 (on the inclusion), weighted by the recovered fluorophore
value. A shadow of the inclusion location is shown overlaid. Shown below the sensitivity maps are the fluorescence intensities at all nearest-neighbor
source-detector pairs, with the two pairs corresponding to the sensitivity maps highlighted. The inclusion to background contrast ratio here is 8:1.
(c) Spectral fitting of transmitted white light. Each line shows the contribution of a fitted parameter to the final spectra. Starting with a scattering spectra
at top (- - -), water absorption (blue), collagen absorption (pink, - - -), and blood absorption (red) are added to bring the simulated spectra down to the
measured spectra (o). (d) The raw transmission intensity is plotted for all detection channels when each of the four source channels is illuminated.
(e) The raw fluorescence intensity is plotted for each detection channel when each of the four sources is illuminated (f) Excitation-normalized fluo-
rescence is plotted for each detection channel when each of the four sources are on (black). In addition, the reconstructed fluorescence signal is shown
in blue.
Journal of Biomedical Optics 046008-4 April 2013 • Vol. 18(4)
Flynn et al.: White light-informed optical properties improve ultrasound-guided fluorescence tomography. . .
attributable to PpIX within the measured spectrum at each
source-detector pair [Fig. 3(b) and 3(e)] and a corresponding
transmitted excitation signal value [Fig. 3(d)].
The diffusion-based forward model as described by Davis
et al.32,43 was used to simulate the reference surface excitation
(Φref;x) and expected fluorescence signals (Φcalc;m), where sub-
scripts x and m denote quantities at the excitation and emission
wavelength, respectively, using target optical properties recov-
ered with white light spectroscopy.
The measured, excitation-normalized data ΦBR [ΦBR ¼
Φm∕Φx; Fig. 3(f)] was scaled by the simulated reference data
(Φref;x) to provide a calibrated fluorescence measurement for
each source-detector pair for reconstruction with the NIRFAST
architecture.
Φfl;calib ¼ ΦBRΦref;x:
The fluorescence yield was calculated using an iterative error
minimization algorithm with the objective function
X2 ¼ jjΦfl;calib −Φfl;calcjj2;
where Φfl;calc is the simulated fluorescence signal [Fig. 3(f)].
The corresponding iterative update equation applied was
δημaf ¼ ðJTJ þ λIÞ−1JTδΦ;
where ημaf , the effective fluorescence yield, is the product of the
fluorophore quantum efficiency η and absorption coefficient μaf ,
δημaf is the update parameter, λ is the fixed regularization
parameter, δΦ is the error between Φfl;calib and Φfl;calc at each
iteration, and J is the Jacobian (sensitivity) matrix.
Spatial segmentation information from the co-registered
ultrasound image was incorporated into the reconstruction algo-
rithm, thus drastically reducing the dimensionality of the prob-
lem from fitting fluorescence yield at thousands of mesh nodes
to fitting fluorescence yield at just a few homogeneous regions.
An extensive review of the benefits of spatial prior in FT is pro-
vided in Ref. 31.
The 2-region mesh obtained from the segmented US image
was used to generate a region-mapping matrix k that maps the
Jacobian to a lower dimension:44
J 0 → Jk; where kij ¼

1; node i ∈ regionj
0; otherwise
And the new update equation:
δημaf ¼ ðJ 0TJ 0 þ λIÞ−1J 0TδΦ:
Since FT reconstructions are generally capable only of
recovering the effective fluorescence yield, ημaf , which is
dependent on the quantum yield, molar extinction coefficient,
and concentration of the fluorophore, actual fluorophore con-
centration cannot be calculated without estimates of the other
properties. The quantum yield for PpIX in DMSO was deter-
mined to be η ¼ 0.0046 using the comparative method of
Williams et al.,45 with Kiton Red in DMSO as a standard,
but it is well known that this value varies depending on solvent
and local environment. The PpIX molar extinction coefficient
at 633 nm is 4866 M−1cm−1,46 as found on the Oregon
Medical Laser Center website (http://omlc.ogi.edu/). Using this
molar extinction coefficient and the known PpIX concentrations,
effective quantum yield was calculated for each experimental
series.
2.3 Experimental Validation Studies
2.3.1 Phantoms
In order to examine the sensitivity of the USFT system to chang-
ing PpIX concentration in a homogeneous medium, the system
was tested using homogeneous liquid phantoms containing
Intralipid (20%, Fresenius-Kabi, Bad Homburg, Germany), 5%
Tween20 (P1379, Sigma-Aldrich), porcine whole blood (7204901,
Lampire Biological inc.), and [0,0.025,0.05,0.1,0.2,0.4,0.8]
μg∕ml PpIX. Blood and Intralipid concentrations were varied
to generate a sampling cross using: values for (blood%,
Intralipid%) were (1%, 0.5%) (1%, 1%) (1%, 1.5%) (0.5%, 1%)
(1.5%, 1%). Each phantom was stirred continuously until
imaging.29,47 Three images were obtained for each combination
of blood, Intralipid, and PpIX concentration, resulting in 15
measurements at each PpIX concentration, with three measure-
ments for each of the five blood/Intralipid values. Recon-
struction was performed in two stages. First, all phantoms were
assumed to have equal optical properties based on values found
in Ref. 34. Second, reconstructions were performed with phan-
tom-specific optical properties, as measured by white light spec-
troscopy. Simulations were used to expand the range of optical
properties, beyond those found in phantoms with 1 0.5%
blood (fully oxygenated), 1 0.5% Intralipid. These simula-
tions considered homogeneous phantoms with base optical
properties of ðμa;x; μa;mÞ ¼ ð0.2; 0.15Þ or ð0.02; 0.015Þmm−1
and ðμ 0s;xμ 0smÞ ¼ ð2.5; 2.0Þmm−1, with each optical property
pair varied by factors of [0.5, 0.75, 1, 1.25, 1.5], and across
7 PpIX concentrations, for a total of 350 simulations. The
simulated data, Φfl;sim þ 5% noise, was reconstructed using
either the fixed base optical properties or the “measured”
(known) optical properties with 5% noise. Normalized standard
deviation (std∕mean), reconstruction objective function error,
E ¼ Σ20i¼1ðlog datai − log reconiÞ2, and reconstruction linearity
with concentration were calculated in each case for all optical
property sets and compared to determine the effect of known
optical properties on reconstructed values.
To examine the ability of the USFT system to resolve chang-
ing PpIX concentration in a small region of interest surrounded
by a background with low-level fluorescence, phantoms consist-
ing of two regions, a background and a 10 × 40 × 4 mm fluo-
rescent inclusion, were constructed using 10% w/v gelatin
(G2500, Sigma-Aldrich), 0.085% w/v TiO2 (14021, Sigma-
Aldrich) for optical and ultrasound scattering, 1% porcine
whole blood (7204901, Lampire Biological Inc.) for absorption,
varying concentrations of PpIX (P8293, Sigma-Aldrich), and
5% Tween20 (P1379, Sigma-Aldrich) to prevent PpIX aggrega-
tion. Gelatin was dissolved in hot water, stirred vigorously
until cooled to 30°C, then mixed with the remaining ingredients
and poured into molds. Inclusions were cast using negative
molds, and backgrounds were cast with positive molds posi-
tioned to leave inclusion-sized holes. The bulk background con-
tained a constant concentration of 0.1 μg∕ml (177 nM) of PpIX,
while the inclusions contained [0.1,0.2,0.4,0.6,0.8,1.0] μg∕ml
PpIX. A 2-mm-thick skin-simulating layer having the same
composition as the bulk background was prepared as well,
and phantoms were imaged with and without the skin-simulat-
ing layer.
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2.3.2 Animal models
For a preliminary study of application of the USFT system to
measured PpIX in a region of interest in vivo, approximately
150 μl of Matrigel (#356231 BD Biosciences), with either 0
or 0.2 μg∕ml of PpIX, was injected intra-dermally into the
hind flank and abdomen of 6-week-old nude mice. The injec-
tions were made while drawing the syringe out, to form
broad flat shapes, in an attempt to mimic BCC structure. Once
solidified, injections were imaged using the USFT system with
the inclusion centered in the image frame. Unpaired pre-injec-
tion images were captured and averaged for autofluorescence
basis spectra. US images were segmented manually based on
the hypoechoic nature of Matrigel injections and processed
as detailed above. This approach to in vivo imaging was highly
controllable for this validation phase of the instrument.
3 Results
A representative fluorescence spectral fit, for data measured on
an inclusion phantom, is presented in Fig. 3(a). The combined
target/system autofluorescence signals all follow trends similar
to the autofluroescence spectra in Fig. 3(a). The excitation-light-
normalized PpIX spectral fitting coefficients, termed the Born-
normalized fluorescence, are shown in the bar plot in Fig. 3(b)
for all nearest neighbor source-detector pairs. Fluorescence
intensity from a projection that sampled the bulk of the fluores-
cence inclusion and a second projection that sampled just the
background, as illustrated by the plotted sensitivity matrices,
are highlighted. A representative white light spectral fit is
shown in Fig. 3(c), with each line representing the added spec-
tral effects of a fitted parameter. Figure 3(d) and 3(e) shows
all 20 measured PpIX coefficients and all 20 measured transmit-
ted excitation values, respectively, with the source location
plotted for each five measurements (serial source illumination
with parallel detection). Figure 3(f) shows the normalized
(Fluorescence/Excitation) PpIX coefficients and the results re-
constructed signals using the optical properties determined in
Fig. 3(c). Note the reconstruction accurately matches the mea-
sured signal.
For homogeneous liquid phantoms, the bulk optical proper-
ties were calculated using white light spectroscopy and used in
the reconstruction of fluorescence yield over a range of PpIX
concentrations. The results were compared to effective fluores-
cence yield obtained using a fixed set of literature-based optical
properties (μa;x¼0.2mm−1, μa;m¼0.15mm−1, μ0s;x¼3.0mm−1,
and μ 0s;m ¼ 2.5 mm−1) for all phantoms (Fig. 4). In Fig. 4(a)
the reconstruction fitting errors (objective function) are plotted
against known PpIX concentration in liquid phantoms, for
reconstructions using optical properties calculated for individual
phantoms using white light spectroscopy. The reconstructed
fluorescence yield using measured optical properties is plotted
against known PpIX concentration in Fig. 4(b). The use of
the correct optical properties for the reconstruction model
lead to significant reduction in reconstruction fitting errors,
by a factor of 8.9 5.1 [mean std, Fig. 4(a)], and lower nor-
malized variation (standard deviation/mean) in reconstructed
fluorescence yield by a factor of 2.0 0.6 (data not shown).
The reconstructed fluorescence values were linear with PpIX
concentration, with R2 ¼ 0.96 for fixed literature based optical
properties (data not shown) and R2 ¼ 0.98 for white light-
measured optical properties [Fig. 4(b)]. Based on reconstructed
fluorescence yield, PpIX molar extinction coefficient, and
known concentration, the calculated quantum efficiency, η, was
roughly 0.0025 for homogeneous liquid blood and Intralipid
phantoms.
It is worth noting that measurement of optical properties
using white light spectroscopy revealed that the optical absorp-
tion values of 1% blood, 1% Intralipid phantoms, when mixed in
an open (oxygenated) environment, were surprisingly low (near
the lower limit of the expected range of absorption for tissues) at
the wavelengths of interest (633 and 700 nm) due to the much
lower absorption of oxygenated hemoglobin in these regions.48
Thus, the homogeneous phantom series did not cover the full
range of interest of optical absorption values. To investigate
the importance of accurate optical properties for fluorescence
reconstruction over the full range of expected tissue optical
properties, signals were simulated over a range of optical prop-
erties centered at absorptions one and two orders of magnitude
higher than the phantom absorption and analyzed. The normal-
ized standard deviations and reconstruction fitting errors were
significantly improved as for the imaged homogeneous phantom
series. Even with 5% noise added to both the simulated fluores-
cence signal and the “measured” (known) optical properties,
reconstruction with informed optical properties provides signifi-
cant improvements over standard reconstructions in simulated
homogeneous phantoms, similar to the improvements seen in
the real homogeneous phantoms (Fig. 4).
Fig. 4. Recovery of PpIX fluorescence yield in homogenous liquid phantoms. (a) Comparison of reconstruction fitting errors (objective function:
E ¼ Σ20i¼1ðlog datai − log reconiÞ2) between literature-based, fixed optical properties (×), and measurement-specific optical properties determined
with white light spectroscopy (+). The errors are significantly lower using white light properties at all PpIX concentrations (*, p < 0.005).
(b) Reconstruction performed using measurement-specific optical properties determined with white light spectroscopy. Results are linear, R2 ¼ 0.98.
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Figure 5 shows a representative inclusion reconstruction and
the benefits of prior spatial information and accurate optical
property information. Figure 5(b) shows hot spots in the un-
informed (no US guidance, ill-posed) reconstruction and the
obviously poor fluorophore mapping when using only FT.
Figure 5(c) compares reconstruction fits using literature-based
or white light spectroscopy measured optical properties for a
single inclusion. Optical properties used from the literature
were based on known absorption and scattering of blood,
Intralipid, and gelatin. Note the reconstruction fitting algorithm
cannot adequately scale the intensity range, based largely on
absorption, to reproduce measured data by changing only the
fluorophore concentration. In Fig. 5(d) note that in two-region
reconstruction, there are only two fluorophore values calculated
when using prior spatial information: homogeneous values in
the inclusion region and the background region.
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af=1.9x10-6 
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Fig. 5 Inclusion fluorescence reconstruction improvements with addition of spatial information and white light-determined optical properties. (a) US
image outline of a phantom inclusion that contains 4:1 PpIX:background contrast is shown. The phantom includes a 2-mm top layer above the inclu-
sion. (b) Reconstruction without spatial priors. The ημaf spatial map is overlaid on the ultrasound image. Color axis corresponds to ημaf . Note “hot spots”
three orders of magnitude higher than values in (d). (c) Reconstructed source-detector measurement fits with and without use of white light-measured
optical properties. Note that without correct absorption coefficients, the correct range of signal intensities for varying source-detector separations
cannot be reproduced by varying only fluorophore concentration, which is why the fixed optical property reconstruction fails to reproduce the mea-
sured data. (d) Regional fluorescence reconstruction with use of spatial priors and measurement-specific optical properties.
(a) (b)
Fig. 6 Reconstruction of inclusion phantom fluorescence yield. Blue data is from phantoms with a 2-mm skin-simulating top layer, red data is from
phantoms without a skin layer. (a) Recovered PpIX yield in the inclusion (open markers) and background (solid markers). Both reconstructions are
linear, with R2 ¼ 0.98. Sensitivity, based on intercept, is ∼0.1 μg∕ml PpIX. (b) Inclusion contrast-to-background ratio in both types of phantoms. The
linear fit equations are y ¼ 1.8x − 0.5, R2 ¼ 0.76, and y ¼ 1.2x − 1.0, R2 ¼ 0.78, for phantoms with and without the skin-simulating top layer,
respectively.
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Figure 6(a) shows reconstructed fluorescence yield versus
known fluorophore concentration for inclusion phantoms with
and without a 2-mm skin-simulating top layer (same fluoro-
phore concentration as background, 0.1 μg∕ml), as well as
the reconstructed background values (same for all inclusions,
0.1 μg∕ml) for each inclusion fluorophore concentration. These
reconstructions were performed using spatial priors from seg-
mented US images [Figure 5(a)] and the actual optical properties
were determined with white light spectroscopy. Reconstructed
values are linear with concentration for inclusions with
and without skin, with R2 ¼ 0.95 for both series, down to
the background concentration and lowest concentration used,
0.1 μg∕ml. Figure 6(b) shows the calculated versus known
contrast to background ratio (CBR), for inclusions with and
without skin-simulating top layers. The linear fit equations
are y ¼ 1.21x − 0.95 (R2 ¼ 0.78) and y ¼ 1.78x − 0.52 (R2 ¼
0.77) for inclusions without and with the skin-simulating top
layers, respectively. The mean error in recovered CBR is 23%
without a top layer and 74% with a top layer. The CBR slope is
near unity for the plain inclusion phantom, but is considerably
higher when a skin-simulating layer is added. When all FT
fiber pairs sample a uniform layer and spatial information is
not available, the solution is nonunique because fluorophore
concentration and depth are no longer independent parameters.
The addition of US-guidance provides more accurate recon-
struction through layers, as Fig. 6 shows, but does not com-
pletely solve this reconstruction issue. Based on reconstructed
fluorescence yield, PpIX molar extinction coefficient, and known
concentration, the quantum efficiency, η, was roughly 0.0024
for gelatin-based blood and Intralipid phantoms without a skin-
simulating top layer.
Finally, Fig. 7 shows a combined USFT reconstruction
image for a 150 μL subcutaneous hind-flank injection of
0.2 μg∕ml PpIX-matrigel solution in a nude mouse. The recon-
structed fluorescence yield, combined with the molar extinction
coefficient, indicated that the quantum efficiency, η, was roughly
0.001, indicating the quantum yield calibration value may be
significantly different in vivo compared to Intralipid- and
gelatin-based phantoms. Contrast to background is not an infor-
mative metric for this case, as it is influenced by the near 0
background.
4 Discussion
This paper presents the validation of a combined high frequency
US-guided reflectance-mode-FT system, with spectral fitting to
decouple multiple signals and novel use of white light spectros-
copy to inform optical models for accurate reconstruction of
regional, subsurface fluorescence yield in vivo. The data show
that the US-guided spatial priors are critical for accurate regional
fluorescence reconstruction. The data also underscore the ben-
efit of white light spectroscopy and the necessity for knowledge
of optical properties for accurate fluorescence tomographic
reconstruction.
The perturbative influence that variations in background
optical properties have on the reconstructions of raw fluores-
cence spectra is shown in Fig. 4(a). While it is possible to
estimate a linear metric of fluorescence from reconstructions
with assumed background optical property values, the overall
reconstruction accuracy of fluorescence estimates are improved
significantly when sample-specific optical properties are mea-
sured by white light spectroscopy and used to inform recon-
struction models. This improvement in accuracy results in
reduction in the normalized standard deviation of reconstructed
fluorescence yield by a factor of ∼2 across varying phantom
optical properties and reduction in reconstruction fitting errors
by a factor of ∼9. In many imaging applications, the region of
interest may be pathologically altered and thus tissue optical
properties may differ from values expected in normal tissue. The
data in this study suggests that incorporation of white light spec-
troscopy to determine these bulk properties will significantly
reduce fluorescence reconstruction errors in vivo.
FT approaches that focus on diffuse recovery exclusively are
often limited by an ill-posed problem of estimating both mag-
nitude and spatial location of fluorescence origin within the
sampled medium. The benefit of using US images to provide
prior spatial information to overcome this limitation is made
obvious in Fig. 5(b). The non-region-segmented problem is
highly under-determined and the reconstruction algorithm can-
not yield accurate spatial maps of subsurface fluorescence.19,20
Standard reconstruction typically yields sparsely distributed hot
spots surrounded by relatively low values [Fig. 5(b)]. While
such a result does very accurately fit the input measured
data, the solution is not unique and does not provide an inform-
ative description of subsurface fluorescence distribution. When
the reconstruction is constrained to a few homogeneous regions,
the problem is no longer ill-posed and yields a more-accurate
regional fluorescence yield, with the trade-off that spatial reso-
lution is reduced to a few homogeneous regions.
The optical phantoms utilized in this study were constructed
to mimic the clinically relevant problem of assessing PpIX fluo-
rescence within a subsurface structure, such as a BCC or SCC.
This situation has multiple complicating factors, including var-
iable target size and depth, variable thickness of overlaying
(nontargeted) tissue, and variations in the contrast ratio between
the target and background. The data in this study show that for a
10-mm-wide × 4-mm-thick fluorescent inclusion with CBR
ranging from ∼1.5 to 10, the US-guided FT method produces
reasonable results, with measured fluorescence yield, ημaf ,
roughly equal in the background and inclusion at 1:1 known
CBR and then linearly increasing with inclusion concentration
[Fig. 6(a) and 6(b)]. The addition of a skin-simulating top layer
leads to an apparent overestimation of the ημaf , though this
is likely due, at least in part, to the compression of the top
layer during imaging. Optical signal intensities decrease with
2mm 
 µaf=3.6x10-6 mm-1 
 µaf=2.2x10-5 mm-1 
Fig. 7 Preliminary in vivo data. Sample US and fluorophore
reconstruction images for a 0.2 μg∕ml 150 μl subcutaneous inclusion
in a nude mouse. Contrast to background is less meaningful for an
injected fluorophore, where the background is near 0.
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increasing depth, so if the 2-mm top layer is actually compressed
to 1.5 mm, then the measured sublayer fluorescence signals
would be higher than expected for a 2-mm layer, and the result-
ing reconstructions would yield an increased fluorescence yield
within the inclusion and higher inclusion:background contrast.
This study presents data obtained in controlled situations
using tissue phantoms and a well-behaved preclinical model.
The phantoms used in this study are simple geometric models
that we are able to easily segment into two or three clearly
defined, uniform regions. In vivo measurements, however, will
be complicated by heterogeneity in both structural (see Fig. 7)
and optical maps, which will tend to decrease local fluorophore
reconstruction accuracy. However, for the designed use, PDT
assessment, regional fluorescence contrast is a useful metric for
deciding when to treat and for evaluating treatment efficacy.
In future work, the high-resolution ultrasound images will be
used to segment the imaged medium into multiple regions if
necessary. Additionally, while the current white light spectros-
copy routine provides estimates of bulk tissue optical properties,
and does not account for heterogeneities, the workflow will be
adjusted in future versions of the system to obtain estimates of
optical properties specific to each source-detector measurement.
PpIX concentration is difficult to calculate because the quan-
tum yield varies for different solvents and conditions, and can-
not be accurately measured in scattering media such as tissue
phantoms. So the measured fluorescence yield only provides
a rough estimate of concentration. It is not possible to know the
effective quantum yield in vivo, and so the results here most
importantly demonstrate that USFT fluorescence yield recon-
struction is linear with known concentration, and that the re-
constructed contrast is relatively accurate. For the desired
applications in PDT assessment and guidance, the fluorescence
yield is actually a more important metric than the fluorophore
concentration or quantum yield, because the treatment dose is
directly related to the fluorescence yield.
Finally, an additional limitation is that reconstruction was
performed using diffusion-theory-based finite element models
to account for the influence of background tissue optical proper-
ties on the collected fluorescence intensity. A more accurate
method would likely be to utilize the optical properties gained
from white light spectroscopy to estimate the intrinsic fluores-
cence, and then reconstruct the fluorescence yield based on
the intrinsic fluorescence instead of the collected fluorescence
using either NIRFAST or a Monte Carlo-based reconstruction
algorithm.
Additional in vivo tests using injected fluorophore to deter-
mine absolute fluorescence yield, concentration, contrast, region
size, and region depth sensitivities will complete validation of
the USFT method and system for spatial quantification of
PpIX in vivo. USFT imaging will then be employed to measure
the spatial production of PpIX for diagnostic purposes and
for evaluation of treatment efficacy during PDT for deep
skin tumors. The USFT methods presented here can also be
readily applied to measure regional fluorescence of other fluo-
rophores to quantify drug delivery, targeted binding, or molecu-
lar function.
5 Conclusion
This study provides a new hybrid imaging/optics approach to
region-based molecular imaging of subsurface targets in vivo.
The presented data demonstrates that ultrasound-guided fluores-
cence tomography (USFT) can be employed to determine
region-based PpIX fluorescence at greater depths than standard
surface-imaging techniques, and could provide PpIX imaging
for tumor detection and delimitation as well as for PDT guid-
ance and dosimetry. The method presented here combines tissue
spatial information (US) with an array of diffuse optical samples
to reconstruct fluorescence yield in tumor and background
regions. Fluorescence spectral fitting is used to isolate the fluo-
rophore of interest from autofluorescence and white light spec-
tral fitting is used to accurately inform the optical models for
reconstruction. We present preliminary in vivo results support-
ing the claim that USFT dual imaging offers rapid, noninvasive,
ionizing-radiation-free measurement of relative region-based
fluoresence of a drug of interest using a portable, low-cost im-
aging system.
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